About Cellix Bio
Cellix Bio is a Healthcare company based in Hyderabad (India) founded in 2014 by Mahesh Kandula. Drug discovery is accelerated by AI platform for diseases. Cellix Bio has raised $4.64 million across 5 funding rounds from investors including V ClinBio, Jan Pieter Werkman and Deepak Maheshwari. Cellix Bio was last valued at $188.21 million in June 2021. Its chief executive, as recorded, is Mahesh Kandula. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity in India is Cellix Bio Private Limited (U74900TG2014PTC094095).
Company details
Cellix was founded in 2014 in Hyderabad, India, within the biotechnology sector. An AI-driven platform is operated for drug discovery and development focused on neurological, inflammatory, and metabolic diseases. The proprietary Synergix AI is employed to design novel molecular entities exhibiting synergistic pharmacological effects, thereby streamlining the identification of drug candidates. A range of therapeutic assets is maintained across these disease areas.
- Headquarters Hyderabad, India
- Founders Mahesh Kandula
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cellixbio.com
- Social LinkedIn X Facebook
- Legal Name Cellix Bio Private Limited
- Date of Incorporation 21 May, 2014
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹61,900
FY 2024 · -71% YoY
- Net Loss-₹58.5 Lakh
FY 2024 · -9454% margin
- EBITDA-₹8.7 Lakh
FY 2024 · -1409% margin
- Total Equity Funding$4.64M (USD)
in 5 rounds
- Latest Funding Round$493.47K (USD), Angel Round
Jun 2021
- InvestorsV ClinBio
& 8 more
Associated legal entities of Cellix Bio
Cellix Bio is associated with 2 registered companies on The Company Check; the primary company is Cellix Bio Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cellix Bio Private Limited CIN U74900TG2014PTC094095 | Active | 21 May 2014 | Hyderabad, Telangana | ₹0.0 Cr | 5 | View details | |
| Cellix Bio Pharma Private Limited CIN U73100TG2020PTC138576 | Active | 21 Jan 2020 | Hyderabad, Telangana | 3 | View details |
Funding Insights of Cellix Bio
Cellix Bio has successfully raised a total of $4.64M across 5 strategic funding rounds. The most recent funding activity was a Angel Round of $493.47 thousand completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.64M
- Total Rounds 5
- Last Round Angel Round — $493,470
- Investors Count 9
All 5 funding rounds of Cellix Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $493,470 | Angel Round | $188.21M | – | |
| Aug 2020 | $997,300 | Series A | $187.39M | Total Clarity | |
| May 2019 | $2.2M | Angel Round | $••••• | Chandra Shekhar Shastri | |
| Oct 2018 | $946,400 | Angel Round | $••••• | Deepak Maheshwari | |
| Feb 2018 | Series A | – | V ClinBio | – |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2021 | $188.21M | •••••••• |
| Aug 2020 | $187.39M | •••••••• |
| May 2019 | $••••• | •••••••• |
| Oct 2018 | $••••• | •••••••• |
Full valuation and stage history of Cellix Bio
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $188.21M (Jun 2021). 9 investors in total: 2 institutional and 7 angel.
Investors in Cellix Bio
Cellix Bio has secured backing from 9 investors, including angel and institutional investors. Prominent investors backing the company include V ClinBio, Jan Pieter Werkman and Deepak Maheshwari.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
V ClinBio provides drug discovery and development services for small and large molecules. | 2013 | vclinbio.in | Chennai, India | |
Develops innovative therapeutic technologies to address various medical conditions effectively. | 2001 | totalclarity.com | ||
JP Jan Pieter Werkman | unknown_661205b3f16a420ca | |||
DM Deepak Maheshwari | Angel investor, ex-Microsoft, passionate about tech startups in India | unknown_98fb736339e74e9fa | ||
PD Paresh Dattatraya Sukthankar | unknown_ccdee334d3704cc8b | |||
PL Pratapreddy Lingareddy Gaddam | unknown_436be8c96e984aff9 | |||
CS Chandra Shekhar Shastri | unknown_e57b7292553e41efa | |||
SR Srinivas Reddy Bogala | unknown_bbd0b374be5148869 | |||
MW Mark Werner Messow | unknown_49c71829d9cd4ff59 |
Investor details for Cellix Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cellix Bio Private Limited (Cellix Bio)
Cellix Bio Private Limited is the primary company behind Cellix Bio. The boards of the 2 registered companies of Cellix Bio currently have 4 directors; the longest-serving is Achanna Chowdary Valluri, appointed in 2014. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Achanna Chowdary Valluri DIN 02052690 | Director | 21 May 2014 | 12 yrs 5 mo | Cellix Bio Private Limited |
| Mahesh Kandula DIN 03360152 | Director | 01 Oct 2014 | 12 yrs | Cellix Bio Private Limited, Cellix Bio Pharma Private Limited |
| Subramaniam Apparsundaram DIN 06671538 | Director | 06 Oct 2017 | 9 yrs | Cellix Bio Private Limited, Cellix Bio Pharma Private Limited |
| Sridhar Koganti DIN 07635429 | Director | 27 Dec 2023 | 2 yrs 9 mo | Cellix Bio Private Limited, Cellix Bio Pharma Private Limited |
People of Cellix Bio
8 people are tracked at Cellix Bio (2 in leadership, 3 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership | |
Subbu Apparsundaram | CDO & COO | Leadership |
Paul Jeffrey | Advisor | Board & advisors |
Bruce Nemlich | Business Advisor | Board & advisors |
Bob Oliver | Executive Advisor | Board & advisors |
Mudher Albassam | Pre-clinical Development | Team |
Ashok Rampal | Formulation Development | Team |
Frank Diana | CMC & Regulatory | Team |
Complete people profiles for Cellix Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cellix Bio
Figures of Cellix Bio Private Limited, the primary company behind Cellix Bio, for FY 2024. Revenue was ₹61,900 (-71% year on year). Net loss was -₹58.5 Lakh (-9454% margin). EBITDA was -₹8.7 Lakh (-1409% margin). Revenue has grown at a compounded annual rate of -61% over three years and -75% over five years.
- ₹61,900Revenue · FY 2024 · -71% YoY
- -₹58.5 LakhNet loss · -9454% margin
- -₹8.7 LakhEBITDA · -1409% margin
- ₹22.47 CrPaid-up capital
- -61%Revenue CAGR, 3 years
- -75%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cellix Bio Private Limited are on its company page.
Detailed financial statements for Cellix Bio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Cellix Bio
4 dated milestones of Cellix Bio across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Cellix Bio is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $493K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cellix Bio
Complete news archive for Cellix Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellix Bio
Cellix Bio was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Cellix Bio is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Mahesh Kandula is the CEO of Cellix Bio, as recorded in our data. They have also founded this company.
Cellix Bio is a funded company, having raised a total of $4.64M across 5 funding rounds to date.
The primary company behind Cellix Bio, Cellix Bio Private Limited, reported revenue of ₹61,900 for FY 2024, down 71% year on year.
Cellix was founded in 2014 in Hyderabad, India, within the biotechnology sector. An AI-driven platform is operated for drug discovery and development focused on neurological, inflammatory, and metabolic diseases. The proprietary Synergix AI is employed to design novel molecular entities exhibiting synergistic pharmacological effects, thereby streamlining the identification of drug candidates. A range of therapeutic assets is maintained across these disease areas.
Cellix Bio has 9 investors. Key investors include V ClinBio, Jan Pieter Werkman, Deepak Maheshwari, Paresh Dattatraya Sukthankar, and Pratapreddy Lingareddy Gaddam.
The valuation of Cellix Bio is $188.21M as of Jun 2021.
Cellix Bio is associated with 2 legal entities: Cellix Bio Private Limited, Cellix Bio Pharma Private Limited.
The legal entities of Cellix Bio currently have 5 directors, including Achanna Chowdary Valluri, Mahesh Kandula, Subramaniam Apparsundaram and others.